Kiniksa Pharmaceuticals International, plc
KNSA- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001730430
In the last 90 days, Kiniksa Pharmaceuticals International, plc insiders filed 0 open-market purchases and 2 sales; 267 institutions reported holding it in 13F filings for Q2 2026, worth $2.99B in total; no superinvestor holds it.
13F holders, Q1 2023
Institutional positions in Kiniksa Pharmaceuticals International, plc as of Mar 31, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 132
- +7 vs. Q4 2022
- Shares held
- 31.8M
- +1.67M (+5.5%) vs. Q4 2022
- Total value
- $339.6M
- −$110.4M (−24.5%) vs. Q4 2022
- New holders
- 23
- 56 more added
- Sold out
- 16
- 33 more reduced
Compare with Q4 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting KNSA on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 267 | $2.99B |
| Q1 2026 | 228 | $2.18B |
| Q4 2025 | 224 | $1.77B |
| Q3 2025 | 204 | $1.59B |
| Q2 2025 | 189 | $1.10B |
| Q1 2025 | 176 | $889.4M |
| Q4 2024 | 160 | $773.1M |
| Q3 2024 | 176 | $991.2M |
| Q2 2024 | 133 | $659.4M |
| Q1 2024 | 154 | $768.1M |
| Q4 2023 | 142 | $600.4M |
| Q3 2023 | 134 | $605.8M |
| Q2 2023 | 127 | $447.7M |
| Q1 2023 | 132 | $339.6M |
| Q4 2022 | 125 | $450.0M |
| Q3 2022 | 104 | $383.2M |
| Q2 2022 | 92 | $290.5M |
| Q1 2022 | 96 | $306.0M |
| Q4 2021 | 103 | $346.4M |
| Q3 2021 | 101 | $332.0M |
| Q2 2021 | 102 | $402.0M |
| Q1 2021 | 105 | $537.6M |
Institutions, Q1 2023
Shares, value and share of portfolio for each institution holding Kiniksa Pharmaceuticals International, plc; share changes are against Q4 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Allspring Global Investments Holdings, LLC | 147,673 | $1.59M | 0.00% | −67,446−31.4% | Reduced |
| Barclays PLC | 162,179 | $1.75M | 0.00% | +102,172+170.3% | Added |
| Healthcare of Ontario Pension Plan Trust Fund | 185,500 | $2.00M | 0.01% | −12,300−6.2% | Reduced |
| Bank of America Corp | 189,019 | $2.03M | 0.00% | +34,573+22.4% | Added |
| UBS Oconnor LLC | 216,210 | $2.33M | 0.06% | +216,210 | New |
| Charles Schwab Investment Management Inc | 217,887 | $2.34M | 0.00% | +12,330+6.0% | Added |
| D. E. Shaw & Co., Inc. | 239,788 | $2.58M | 0.00% | +2,343+1.0% | Added |
| Wellington Management Group LLP | 243,151 | $2.62M | 0.00% | −5,812−2.3% | Reduced |
| Parkman Healthcare Partners LLC | 250,257 | $2.69M | 0.59% | +58,950+30.8% | Added |
| Northern Trust Corp | 292,120 | $3.14M | 0.00% | +5,445+1.9% | Added |
| Jacobs Levy Equity Management, Inc | 293,500 | $3.16M | 0.02% | −30,237−9.3% | Reduced |
| Ameriprise Financial Inc | 371,512 | $4.00M | 0.00% | +14,896+4.2% | Added |
| Dimensional Fund Advisors LP | 377,258 | $4.06M | 0.00% | −15,533−4.0% | Reduced |
| AQR Capital Management LLC | 407,762 | $4.39M | 0.01% | +262,747+181.2% | Added |
| Goldman Sachs Group Inc | 421,933 | $4.54M | 0.00% | −593,975−58.5% | Reduced |
| Sphera Funds Management Ltd. | 450,283 | $4.85M | 1.05% | +143,000+46.5% | Added |
| Geode Capital Management, LLC | 569,329 | $6.13M | 0.00% | +24,992+4.6% | Added |
| Granahan Investment Management Inc | 574,940 | $6.19M | 0.19% | +70,747+14.0% | Added |
| Tang Capital Management LLC | 600,000 | $6.46M | 0.96% | 00.0% | Unchanged |
| Millennium Management LLC | 626,198 | $6.74M | 0.01% | −144,452−18.7% | Reduced |
| Rice Hall James & Associates, LLC | 655,656 | $7.05M | 0.40% | −41,506−6.0% | Reduced |
| Marshall Wace, LLP | 806,825 | $8.68M | 0.02% | +658,886+445.4% | Added |
| Hudson Bay Capital Management LP | 860,200 | $9.26M | 0.10% | +260,200+43.4% | Added |
| ArrowMark Colorado Holdings LLC | 886,870 | $9.54M | 0.11% | +169,699+23.7% | Added |
| HHLR Advisors, Ltd.SuperinvestorHHLR Advisors (Hillhouse) | 1,018,091 | $11.0M | 0.19% | −1,605,833−61.2% | Reduced |
| Morgan Stanley | 1,325,822 | $14.3M | 0.00% | +720,278+118.9% | Added |
| Pictet Asset Management SA | 1,443,027 | $15.5M | 0.02% | +208,834+16.9% | Added |
| State Street Corp | 1,797,444 | $19.3M | 0.00% | +307,333+20.6% | Added |
| Rubric Capital Management LP | 2,775,636 | $29.9M | 1.19% | +1,206,133+76.8% | Added |
| Baker Bros. Advisors LP | 2,799,577 | $30.1M | 0.16% | 00.0% | Unchanged |
| Vanguard Group Inc | 3,260,623 | $35.1M | 0.00% | +33,732+1.0% | Added |
| BlackRock Inc. | 3,386,160 | $36.4M | 0.00% | −195,519−5.5% | Reduced |
| Hillsdale Investment Management Inc. | 0 | $0 | 0.00% | −244,017−100.0% | Sold out |
| EAM Global Investors LLC | 0 | $0 | 0.00% | −116,864−100.0% | Sold out |
| Cubist Systematic Strategies, LLC | 0 | $0 | 0.00% | −110,620−100.0% | Sold out |
| EAM Investors, LLC | 0 | $0 | 0.00% | −79,046−100.0% | Sold out |
| Caxton Associates LP | 0 | $0 | 0.00% | −66,055−100.0% | Sold out |
| Victory Capital Management Inc | 0 | $0 | 0.00% | −65,900−100.0% | Sold out |
| Walleye Capital LLC | 0 | $0 | 0.00% | −48,217−100.0% | Sold out |
| HRT Financial LP | 0 | $0 | 0.00% | −39,751−100.0% | Sold out |
| Y-Intercept (Hong Kong) Ltd | 0 | $0 | 0.00% | −12,920−100.0% | Sold out |
| Rockefeller Capital Management L.P. | 0 | $0 | 0.00% | −5,750−100.0% | Sold out |
| Quantbot Technologies LP | 0 | $0 | 0.00% | −5,604−100.0% | Sold out |
| Lazard Asset Management LLC | 0 | $0 | 0.00% | −4,648−100.0% | Sold out |
| Altshuler Shaham Ltd | 0 | $0 | 0.00% | −3,956−100.0% | Sold out |
| Balyasny Asset Management LLC | 0 | $0 | 0.00% | −2,695−100.0% | Sold out |
| Metropolitan Life Insurance Co | 0 | $0 | 0.00% | −1,846−100.0% | Sold out |
| Quadrant Capital Group LLC | 0 | $0 | 0.00% | −585−100.0% | Sold out |